Streetbeat News

Products Services

SNDX

Syndax Pharmaceuticals announced that data from its pivotal AUGMENT-101 trial of Revumenib for treating relapsed/refractory KMT2Ar acute leukemia has been selected for a late-breaking presentation at the 65th ASH Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:09 pm

SCLX

Scilex Holding Company (NASDAQ:SCLX) announced an increase in manufacturing of ELYXYB, a non-opioid pain management product for migraines, to meet rising demand. The company has produced its first commercial batch with Scilex labeled ELYXYB, aiming to address the needs of future customers. ELYXYB is FDA-approved and has shown effectiveness in clinical trials. The U.S. migraine drug market is estimated at $4.1 billion in 2022. Scilex's CEO expressed excitement about ELYXYB's potential since its April 2023 launch.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:09 pm

SPR

Skyrora and Spirit AeroSystems have announced a collaboration to enhance the UK's orbital launch capabilities. Skyrora aims to be the first UK company to launch satellites from UK soil, with up to 16 launches per year planned. The partnership will leverage Spirit's manufacturing and testing facilities in the UK to transition Skyrora's vehicles from development to full-scale production. The collaboration aligns with the UK Government's National Space Strategy to become Europe's leading provider of small satellite launch by 2030. The partnership also includes research in space technologies, such as additive manufacturing, with Skyrora providing access to its Skyprint 2 3D printer.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:08 pm

NVDA

WIT

Wipro has partnered with NVIDIA to leverage generative AI for healthcare insurance companies, utilizing NVIDIA's AI Enterprise software. This collaboration combines the strengths of both companies in AI and large language models to innovate in the healthcare insurance sector.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:08 pm

LOVE

MSFT

Lovesac and Xbox have partnered for a second year to offer an exclusive Cyber Monday deal featuring Lovesac's StealthTech with invisible surround sound technology, aiming to enhance the gaming experience for the holiday season.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:06 pm

DOGEUSD

Crypto analyst Tony 'The Bull' identified a technical signal in Dogecoin's price activity, the one-month Parabolic Stop and Reverse (SAR), which he believes could precede a significant rally similar to a past 23,000% increase. Another analyst, Crypto Tony, also suggested a potential rally based on technical indicators and accumulation patterns. Currently, Dogecoin is trading at $0.076, down 5.38% over the last 24 hours.

Portfolio Pulse from Mehab Qureshi

November 21, 2023 | 2:05 pm

ATIF

ATIF Holdings Limited (NASDAQ:ATIF) has announced that its subsidiary, ATIF Business Management LLC, has signed an $800,000 listing advisory services agreement with a U.S.-based electronic technology innovation company. The services include guiding the client through the IPO process with various support services such as audit, valuation, and investor relations. ATIF's CEO, Liu Jun, expressed commitment to client success and the establishment of a strong cooperative relationship.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:02 pm

AMZN

C3 AI has announced the AWS Marketplace listing of its no-code, self-service generative AI application, C3 Generative AI: AWS Marketplace Edition. Starting November 29, select customers can access a 14-day free trial via private preview. The application is designed to transform enterprise work by enabling users to easily find information and insights within data. It will be publicly available to all AWS customers soon and is already deployed in various industries. All C3 AI products run on AWS and utilize AWS's AI/ML capabilities, including Amazon Bedrock.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:02 pm

CMCSA

INTC

AI21 has completed a $208 million Series C funding round, reaching a valuation of $1.4 billion with investments from Intel Capital and Comcast Ventures. This funding increases AI21's total capital to $336 million, aiming to accelerate the adoption of AI-first enterprise solutions. Intel Capital's Anthony Lin highlighted AI21's full-stack offering, while AI21's co-CEO Ori Goshen emphasized the importance of catering to enterprises' specific needs.

Portfolio Pulse from Anusuya Lahiri

November 21, 2023 | 2:00 pm

HRST

LLY

MASI

MDGL

NVO

PFE

Tema has launched the Tema Cardiovascular and Metabolics ETF (HRST) focusing on companies like Novo Nordisk (NVO), which makes Ozempic, and Eli Lilly (LLY), maker of Mounjaro. Semaglutides, including Ozempic and Mounjaro, have shown significant weight loss and organ protection benefits. NVO's stock has surged 281% since Ozempic's 2019 launch, while LLY's shares jumped nearly 80% post-Mounjaro's 2022 launch. In contrast, Pfizer (PFE), without a semaglutide, has seen a 51% decline since December 2021. HRST aims to capitalize on the lucrative cardiovascular and obesity treatment market, also including companies like Masimo (MASI) and Madrigal Pharmaceuticals (MDGL).

Portfolio Pulse from Neil Dennis

November 21, 2023 | 1:55 pm